BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 15284269)

  • 1. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
    Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
    J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2.
    Chemaly RF; Sharma PS; Youssef S; Gerber D; Hwu P; Hanmod SS; Jiang Y; Hachem RY; Raad II
    Int J Infect Dis; 2010 Jul; 14(7):e548-52. PubMed ID: 20005762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
    Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
    Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
    J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience.
    Ramos ER; Reitzel R; Jiang Y; Hachem RY; Chaftari AM; Chemaly RF; Hackett B; Pravinkumar SE; Nates J; Tarrand JJ; Raad II
    Crit Care Med; 2011 Feb; 39(2):245-51. PubMed ID: 21057308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.
    León C; Ruiz-Santana S; Rello J; de la Torre MV; Vallés J; Alvarez-Lerma F; Sierra R; Saavedra P; Alvarez-Salgado F;
    Intensive Care Med; 2004 Oct; 30(10):1891-9. PubMed ID: 15278273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
    Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
    Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection.
    Abdelkefi A; Achour W; Ben Othman T; Ladeb S; Torjman L; Lakhal A; Ben Hassen A; Hsairi M; Ben Abdeladhim A
    J Support Oncol; 2007 Jun; 5(6):273-8. PubMed ID: 17624052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.
    Darouiche RO; Berger DH; Khardori N; Robertson CS; Wall MJ; Metzler MH; Shah S; Mansouri MD; Cerra-Stewart C; Versalovic J; Reardon MJ; Raad II
    Ann Surg; 2005 Aug; 242(2):193-200. PubMed ID: 16041209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I; Davis S; Becker M; Hohn D; Houston D; Umphrey J; Bodey GP
    Arch Intern Med; 1993 Aug; 153(15):1791-6. PubMed ID: 8392831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
    Yücel N; Lefering R; Maegele M; Max M; Rossaint R; Koch A; Schwarz R; Korenkov M; Beuth J; Bach A; Schierholz J; Pulverer G; Neugebauer EA
    J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.
    Abdelkefi A; Torjman L; Ladeb S; Othman TB; Achour W; Lakhal A; Hsairi M; Kammoun L; Hassen AB; Abdeladhim AB
    J Clin Oncol; 2005 Nov; 23(31):7864-70. PubMed ID: 16258088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
    Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
    J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.
    Raad I; Darouiche R; Dupuis J; Abi-Said D; Gabrielli A; Hachem R; Wall M; Harris R; Jones J; Buzaid A; Robertson C; Shenaq S; Curling P; Burke T; Ericsson C
    Ann Intern Med; 1997 Aug; 127(4):267-74. PubMed ID: 9265425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.